Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain scans reveal best Anti-Vaping ads to stop young vapers from smoking

NCT ID NCT05447325

Knowledge-focused Sponsor: University of Georgia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether showing anti-vaping messages to young adults who vape can keep them from starting to smoke cigarettes. 180 participants will have their brains scanned and then receive different types of anti-vaping ads over a year. Researchers will track their vaping, smoking, and nicotine use to see which messages work best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Anti-vaping public service announcement images
What this could lead to
If successful, this could show which anti-vaping messages work best to keep young vapers from starting to smoke cigarettes.
What could go wrong
This is an early-stage study focused on measuring brain activity and survey responses, not on proving a treatment works. Results may not lead to a clear intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2022

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 29 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * used e-cigarettes or other vaping devices at least 3 days during the past 30 days * did not smoke a cigarette, even one or two puffs, during the past 30 days * Magnetic resonance imaging (MRI) compatible and safe Exclusion Criteria: * used e-cigarettes or other vaping devices for less than 3 days during the past 30 days * any use of cigarettes during the past 30 days * history of a major neurological, psychiatric, or medical disorder * MRI contraindications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Message exposure (sequence: flavor then regular) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Message exposure (sequence: flavor then regular) Message exposure (sequence: regular then flavor) No message exposure (control condition)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UGA Bio-imaging Research Center

    RECRUITING

    Athens, Georgia, 30602, United States